Henry Schein Inc (NAS:HSIC)
$ 68 -1.43 (-2.06%) Market Cap: 8.48 Bil Enterprise Value: 11.34 Bil PE Ratio: 27.87 PB Ratio: 2.43 GF Score: 83/100

Henry Schein Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 11, 2023 / 02:00PM GMT
Release Date Price: $74.28 (+0.54%)
Erin Elizabeth Wilson Wright
Morgan Stanley, Research Division - Equity Analyst

Hi. Good morning. Good morning, everybody. My name is Erin Wright, I'm the lead healthcare services analyst at Morgan Stanley. We're happy to have with us today, Henry Schein and the management team. So we have Stanley Bergman, Chairman and CEO; as well as Ron South, Senior Vice President and CFO. We also have Graham Stanley in the audience from an IR perspective. And yes, thank you so much for coming. I really appreciate it. I think you would like to make some opening remarks, if you would like, or we can jump right into questions either way.

Stanley M. Bergman
Henry Schein, Inc. - Executive Chairman & CEO

I can make opening remarks. I'll make them very briefly, Erin, and then you can ask your questions. I think that's probably more interesting.

I think investors know Henry Schein is the largest provider of products and related services to office-based practitioners. 2/3 of our business is in the dental and related space and around 30% or so of our business is in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot